"The U.S. Food and Drug Administration today approved Hysingla ER (hydrocodone bitartrate), an extended-release (ER) opioid analgesic to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternat"...
(baclofen) Injection 0.05 mg/mL, 0.5 mg/mL and 2 mg/mL
For intrathecal injection and infusion only
Chemical Name: 4-amino-3-(p-chlorophenyl) butyric acid
Molecular Formula: C10H12ClNO2
Molecular Weight: 213.67
Description: White to off-white, odorless or practically odorless crystalline powder.
Solubility: Slightly soluble in water, very slightly soluble in methanol and insoluble in chloroform.
pKa: pKa, 1 = 3.87 (carboxyl group) and pKa, 2 = 9.62 (amino group) in water at 20OC.
The contents of each sterile ampoule are described in the following table.
|Dosage mg/mL||Total Volume mL||Medicinal ingredient||Non-medicinal ingredients|
|Baclofen/mg||Sodium chloride/mg||Water for injection|
|0.05||1||0.05||9||up to 1 mL|
|0.5||20||10||180||up to 20 mL|
|2||5||10||45||up to 5 mL|
Last reviewed on RxList: 1/10/2014
This monograph has been modified to include the generic and brand name in many instances.
Additional Lioresal Intrathecal Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Chronic Pain/Back Pain
Find tips and advances in treatment.